Similar articles

• A cost effectiveness analysis of the treatment of end stage renal failure.

  Croxson BE, Ashton T. Croxson BE, et al. N Z Med J. 1990 Apr 25;103(888):171-4. N Z Med J. 1990. PMID: 2109846
• Cost analysis of dialysis treatments for end-stage renal disease (ESRD).

  Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN. Goeree R, et al. Clin Invest Med. 1995 Dec;18(6):455-64. Clin Invest Med. 1995. PMID: 8714789
• Cost effectiveness analysis of alternative treatments of end-stage renal disease: Philippine experience.

  Naidas OD, Chan-Licuanan KR, Velasco VP, Dalay CV, Bayog DV, Rosete-Liquete RM. Naidas OD, et al. Transplant Proc. 1998 Nov;30(7):3116. doi: 10.1016/s0041-1345(98)00956-7. Transplant Proc. 1998. PMID: 9838375 No abstract available.
• The costs of dialysis treatments for patients with end-stage renal disease in France.

  Jacobs C. Jacobs C. Nephrol Dial Transplant. 1997;12 Suppl 1:29-32. Nephrol Dial Transplant. 1997. PMID: 9075226 Review. No abstract available.
• [How to choose among 3 treatment options in the care of end stage renal disease: special emphasis on kidney transplantation].

  Shibagaki Y. Shibagaki Y. Nihon Jinzo Gakkai Shi. 2004;46(4):347-59. Nihon Jinzo Gakkai Shi. 2004. PMID: 16773798 Review. Japanese. No abstract available.